The THALEA project is implemented by pre-commercial procurement (PCP). This innovative process presents an opportunity for suppliers to develop new solutions and to introduce new technologies and products in direct cooperation with the target industry. The PCP process is flexible and allows an early dialogue between potential suppliers and the hospitals in order to optimize the ICU telemedicine system. The PCP process can be very beneficial in a situation where there is no existing system yet in the market. The development work will partly be financed by THALEA project funding, within the 7th framework programme of the European Union.
After an initial tender, the PCP process can be divided into three phases:
- In the first phase, the consortium will evaluate the tenders with respect to their technical, economical and organizational viability.
- In the second phase, the suppliers introduce a prototype of the ICU telemedicine systems that have been chosen for further development to prove the functional requirements of the system.
- In the third phase, the suppliers develop a pilot system.
In these phases, all university hospital members of the THALEA project will participate in the product evaluation.
After this phased process, suppliers are able to commercialize their systems and hospitals all over Europe can procure the system according to European Union’s regulation of public procurement.
For more tender information, see Thalea Prior Information Notice in Tenders Electronic Daily (TED).